🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

BRIEF-Mayne Pharma says multiple US states commenced legal proceedings against Mayne

Published 16/12/2016, 11:39 am
© Reuters.  BRIEF-Mayne Pharma says multiple US states commenced legal proceedings against Mayne
MYX
-

Dec 16 (Reuters) - Mayne Pharma Group Ltd MYX.AX -

* Multiple US states commenced legal proceedings in United States District Court Of Connecticut against number of US generic companies including Mayne

* Board continues to believe investigations and legal proceedings will not have a material impact on its future earnings

* US states allege co engaged in conduct in doxycycline hyclate delayed-release market with heritage pharmaceuticals that was anti- competitive

* No assurance can be given as to timing or outcome of investigation or legal proceedings Source text for Eikon: ID:nASX4GhZZz Further company coverage: MYX.AX

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.